Skip to main content
Top
Published in: Respiratory Research 1/2011

Open Access 01-12-2011 | Research

Antigen-Specific IgG ameliorates allergic airway inflammation via Fcγ receptor IIB on dendritic cells

Authors: Yumiko Ishikawa, Kazuyuki Kobayashi, Masatsugu Yamamoto, Kyosuke Nakata, Tetsuya Takagawa, Yasuhiro Funada, Yoshikazu Kotani, Hajime Karasuyama, Masaru Yoshida, Yoshihiro Nishimura

Published in: Respiratory Research | Issue 1/2011

Login to get access

Abstract

Background

There have been few reports on the role of Fc receptors (FcRs) and immunoglobulin G (IgG) in asthma. The purpose of this study is to clarify the role of inhibitory FcRs and antigen presenting cells (APCs) in pathogenesis of asthma and to evaluate antigen-transporting and presenting capacity by APCs in the tracheobronchial mucosa.

Methods

In FcγRIIB deficient (KO) and C57BL/6 (WT) mice, the effects of intratracheal instillation of antigen-specific IgG were analysed using the model with sensitization and airborne challenge with ovalbumin (OVA). Thoracic lymph nodes instilled with fluorescein-conjugated OVA were analysed by fluorescence microscopy. Moreover, we analysed the CD11c+ MHC class II+ cells which intaken fluorescein-conjugated OVA in thoracic lymph nodes by flow cytometry. Also, lung-derived CD11c+ APCs were analysed by flow cytometry. Effects of anti-OVA IgG1 on bone marrow dendritic cells (BMDCs) in vitro were also analysed. Moreover, in FcγRIIB KO mice intravenously transplanted dendritic cells (DCs) differentiated from BMDCs of WT mice, the effects of intratracheal instillation of anti-OVA IgG were evaluated by bronchoalveolar lavage (BAL).

Results

In WT mice, total cells and eosinophils in BAL fluid reduced after instillation with anti-OVA IgG1. Anti-OVA IgG1 suppressed airway inflammation in hyperresponsiveness and histology. In addition, the number of the fluorescein-conjugated OVA in CD11c+ MHC class II+ cells of thoracic lymph nodes with anti-OVA IgG1 instillation decreased compared with PBS. Also, MHC class II expression on lung-derived CD11c+ APCs with anti-OVA IgG1 instillation reduced. Moreover, in vitro, we showed that BMDCs with anti-OVA IgG1 significantly decreased the T cell proliferation. Finally, we demonstrated that the lacking effects of anti-OVA IgG1 on airway inflammation on FcγRIIB KO mice were restored with WT-derived BMDCs transplanted intravenously.

Conclusion

Antigen-specific IgG ameliorates allergic airway inflammation via FcγRIIB on DCs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004, 59: 469-478. 10.1111/j.1398-9995.2004.00526.x.CrossRefPubMed Masoli M, Fabian D, Holt S, Beasley R: The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004, 59: 469-478. 10.1111/j.1398-9995.2004.00526.x.CrossRefPubMed
2.
go back to reference Kinet JP: The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol. 1999, 17: 931-972. 10.1146/annurev.immunol.17.1.931.CrossRefPubMed Kinet JP: The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol. 1999, 17: 931-972. 10.1146/annurev.immunol.17.1.931.CrossRefPubMed
3.
go back to reference Wills-Karp M: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol. 1999, 17: 255-281. 10.1146/annurev.immunol.17.1.255.CrossRefPubMed Wills-Karp M: Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol. 1999, 17: 255-281. 10.1146/annurev.immunol.17.1.255.CrossRefPubMed
4.
go back to reference Avila PC: Does anti-IgE therapy help in asthma? Efficacy and controversies. Annu Rev Med. 2007, 58: 185-203. 10.1146/annurev.med.58.061705.145252.CrossRefPubMed Avila PC: Does anti-IgE therapy help in asthma? Efficacy and controversies. Annu Rev Med. 2007, 58: 185-203. 10.1146/annurev.med.58.061705.145252.CrossRefPubMed
5.
go back to reference Strunk RC, Bloomberg GR: Omalizumab for asthma. N Engl J Med. 2006, 354: 2689-2695. 10.1056/NEJMct055184.CrossRefPubMed Strunk RC, Bloomberg GR: Omalizumab for asthma. N Engl J Med. 2006, 354: 2689-2695. 10.1056/NEJMct055184.CrossRefPubMed
6.
go back to reference Hanania NA: Targeting airway inflammation in asthma: current and future therapies. Chest. 2008, 133: 989-998. 10.1378/chest.07-0829.CrossRefPubMed Hanania NA: Targeting airway inflammation in asthma: current and future therapies. Chest. 2008, 133: 989-998. 10.1378/chest.07-0829.CrossRefPubMed
7.
go back to reference Ogra PL, Faden H, Welliver RC: Vaccination strategies for mucosal immune responses. Clin Mivrobiol Rev. 2001, 14: 430-445. 10.1128/CMR.14.2.430-445.2001.CrossRef Ogra PL, Faden H, Welliver RC: Vaccination strategies for mucosal immune responses. Clin Mivrobiol Rev. 2001, 14: 430-445. 10.1128/CMR.14.2.430-445.2001.CrossRef
8.
go back to reference Miyagawa N, Iwasaki H, Kato T, Tanaka M, Shibata T, Wakitani K: Induction of late airway response was involved in serum antigen-specific immunoglobulin G in rats. Int Immunopharmacol. 2008, 8: 1848-1853. 10.1016/j.intimp.2008.09.003.CrossRefPubMed Miyagawa N, Iwasaki H, Kato T, Tanaka M, Shibata T, Wakitani K: Induction of late airway response was involved in serum antigen-specific immunoglobulin G in rats. Int Immunopharmacol. 2008, 8: 1848-1853. 10.1016/j.intimp.2008.09.003.CrossRefPubMed
9.
go back to reference Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R: Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet. 2001, 357: 752-756. 10.1016/S0140-6736(00)04168-4.CrossRefPubMed Platts-Mills T, Vaughan J, Squillace S, Woodfolk J, Sporik R: Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study. Lancet. 2001, 357: 752-756. 10.1016/S0140-6736(00)04168-4.CrossRefPubMed
10.
go back to reference Aalberse RC, van der Gaag R, van Leeuwen J: Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol. 1983, 130: 722-726.PubMed Aalberse RC, van der Gaag R, van Leeuwen J: Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J Immunol. 1983, 130: 722-726.PubMed
11.
go back to reference Ravetch JV, Kinet JP: Fc receptors. Annu Rev Immunol. 1991, 9: 457-492. 10.1146/annurev.iy.09.040191.002325.CrossRefPubMed Ravetch JV, Kinet JP: Fc receptors. Annu Rev Immunol. 1991, 9: 457-492. 10.1146/annurev.iy.09.040191.002325.CrossRefPubMed
12.
go back to reference Takai T: Roles of Fc receptors in autoimmunity. Nat Rev Immunol. 2002, 2: 580-592.PubMed Takai T: Roles of Fc receptors in autoimmunity. Nat Rev Immunol. 2002, 2: 580-592.PubMed
13.
14.
go back to reference Masuda A, Yoshida M, Shiomi H, Morita Y, Kutsumi H, Inokuchi H, Mizuno S, Nakamura A, Takai T, Blumberg RS, Azuma T: Role of Fc Receptors as a therapeutic target. Inflamm Allergy Drug Targets. 2009, 8: 80-86. 10.2174/187152809787582525.CrossRefPubMedPubMedCentral Masuda A, Yoshida M, Shiomi H, Morita Y, Kutsumi H, Inokuchi H, Mizuno S, Nakamura A, Takai T, Blumberg RS, Azuma T: Role of Fc Receptors as a therapeutic target. Inflamm Allergy Drug Targets. 2009, 8: 80-86. 10.2174/187152809787582525.CrossRefPubMedPubMedCentral
15.
go back to reference Masuda A, Yoshida M, Shiomi H, Ikezawa S, Takagawa T, Tanaka H, Chinzei R, Ishida T, Morita Y, Kutsumi H, Inokuchi H, Wang S, Kobayashi K, Mizuno S, Nakamura A, Takai T, Blumberg RS, Azuma T: Fcgamma receptor regulation of Citrobacter rodentium infection. Infect Immun. 2008, 76: 1728-1737. 10.1128/IAI.01493-07.CrossRefPubMedPubMedCentral Masuda A, Yoshida M, Shiomi H, Ikezawa S, Takagawa T, Tanaka H, Chinzei R, Ishida T, Morita Y, Kutsumi H, Inokuchi H, Wang S, Kobayashi K, Mizuno S, Nakamura A, Takai T, Blumberg RS, Azuma T: Fcgamma receptor regulation of Citrobacter rodentium infection. Infect Immun. 2008, 76: 1728-1737. 10.1128/IAI.01493-07.CrossRefPubMedPubMedCentral
16.
go back to reference Nimmerjahn F, Ravetch JV: Fcgamma receptors: old friends and new family members. Immunity. 2006, 24: 19-28. 10.1016/j.immuni.2005.11.010.CrossRefPubMed Nimmerjahn F, Ravetch JV: Fcgamma receptors: old friends and new family members. Immunity. 2006, 24: 19-28. 10.1016/j.immuni.2005.11.010.CrossRefPubMed
17.
go back to reference McGaha TL, Sorrentino B, Ravetch JV: Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science. 2005, 307: 590-593. 10.1126/science.1105160.CrossRefPubMed McGaha TL, Sorrentino B, Ravetch JV: Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science. 2005, 307: 590-593. 10.1126/science.1105160.CrossRefPubMed
18.
go back to reference Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV: Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science. 1990, 248: 732-735. 10.1126/science.2139735.CrossRefPubMed Qiu WQ, de Bruin D, Brownstein BH, Pearse R, Ravetch JV: Organization of the human and mouse low-affinity Fc gamma R genes: duplication and recombination. Science. 1990, 248: 732-735. 10.1126/science.2139735.CrossRefPubMed
19.
go back to reference Lambrecht BN, Hammad H: Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol. 2003, 3: 994-1003. 10.1038/nri1249.CrossRefPubMed Lambrecht BN, Hammad H: Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol. 2003, 3: 994-1003. 10.1038/nri1249.CrossRefPubMed
20.
go back to reference Lambrecht BN: Allergen uptake and presentation by dendritic cells. Curr Opin Allergy Clin Immunol. 2001, 1: 51-59.CrossRefPubMed Lambrecht BN: Allergen uptake and presentation by dendritic cells. Curr Opin Allergy Clin Immunol. 2001, 1: 51-59.CrossRefPubMed
21.
go back to reference Van Rijt LS, Jung S, KleinJan A, Vos N, Willart M, Duez C, Hoogsteden HC, Lambrecht BN: In vivo depletion of lung CD11c dendritic cells during allergen challenge abrogates the characteristic features of asthma. JEM. 2005, 201: 981-991. 10.1084/jem.20042311.CrossRef Van Rijt LS, Jung S, KleinJan A, Vos N, Willart M, Duez C, Hoogsteden HC, Lambrecht BN: In vivo depletion of lung CD11c dendritic cells during allergen challenge abrogates the characteristic features of asthma. JEM. 2005, 201: 981-991. 10.1084/jem.20042311.CrossRef
22.
go back to reference Kitamura K, Takeda K, Koya T, Miyahara N, Kodama T, Dakhama A, Takai T, Hirano A, Tanimoto M, Harada M, Gelfand EW: Critical role of the Fc receptor gamma-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation. J Immunol. 2007, 178: 480-488.CrossRefPubMed Kitamura K, Takeda K, Koya T, Miyahara N, Kodama T, Dakhama A, Takai T, Hirano A, Tanimoto M, Harada M, Gelfand EW: Critical role of the Fc receptor gamma-chain on APCs in the development of allergen-induced airway hyperresponsiveness and inflammation. J Immunol. 2007, 178: 480-488.CrossRefPubMed
23.
go back to reference Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV: Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature. 1996, 379: 346-349. 10.1038/379346a0.CrossRefPubMed Takai T, Ono M, Hikida M, Ohmori H, Ravetch JV: Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature. 1996, 379: 346-349. 10.1038/379346a0.CrossRefPubMed
24.
go back to reference Barnden MJ, Allison J, Heath WR, Carbone FR: Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol. 1998, 76: 34-40. 10.1046/j.1440-1711.1998.00709.x.CrossRefPubMed Barnden MJ, Allison J, Heath WR, Carbone FR: Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol. 1998, 76: 34-40. 10.1046/j.1440-1711.1998.00709.x.CrossRefPubMed
25.
go back to reference Ishikawa R, Tsujimura Y, Obata K, Kawano Y, Minegishi Y, Karasuyama H: IgG-mediated systemic anaphylaxis to protein antigen can be induced even under conditions of limited amounts of antibody and antigen. BBRC. 2010, 402: 742-746.PubMed Ishikawa R, Tsujimura Y, Obata K, Kawano Y, Minegishi Y, Karasuyama H: IgG-mediated systemic anaphylaxis to protein antigen can be induced even under conditions of limited amounts of antibody and antigen. BBRC. 2010, 402: 742-746.PubMed
26.
go back to reference Renz H, Saloga J, Bradley KL, Loader JE, Greenstein JL, Larsen G, Gelfand EW: Specific V beta T cell subsets mediate the immediate hypersensitivity response to ragweed allergen. J Immunol. 1993, 151: 1907-1917.PubMed Renz H, Saloga J, Bradley KL, Loader JE, Greenstein JL, Larsen G, Gelfand EW: Specific V beta T cell subsets mediate the immediate hypersensitivity response to ragweed allergen. J Immunol. 1993, 151: 1907-1917.PubMed
27.
go back to reference Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med. 1997, 156: 766-775.CrossRefPubMed Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG, Gelfand EW: Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am J Respir Crit Care Med. 1997, 156: 766-775.CrossRefPubMed
28.
go back to reference Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA: Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. JEM. 2001, 193: 51-60. 10.1084/jem.193.12.F51.CrossRef Vermaelen KY, Carro-Muino I, Lambrecht BN, Pauwels RA: Specific migratory dendritic cells rapidly transport antigen from the airways to the thoracic lymph nodes. JEM. 2001, 193: 51-60. 10.1084/jem.193.12.F51.CrossRef
29.
go back to reference Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992, 176: 1693-1702. 10.1084/jem.176.6.1693.CrossRefPubMed Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM: Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med. 1992, 176: 1693-1702. 10.1084/jem.176.6.1693.CrossRefPubMed
30.
go back to reference Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999, 223: 77-92. 10.1016/S0022-1759(98)00204-X.CrossRefPubMed Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999, 223: 77-92. 10.1016/S0022-1759(98)00204-X.CrossRefPubMed
31.
go back to reference Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K: A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 1997, 44: 1299-1305. 10.1016/S0039-9140(97)00017-9.CrossRefPubMed Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K: A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 1997, 44: 1299-1305. 10.1016/S0039-9140(97)00017-9.CrossRefPubMed
32.
go back to reference Sato K, Fujita S: Dendritic cells: nature and classification. Allergol Int. 2007, 56: 183-191. 10.2332/allergolint.R-06-139.CrossRefPubMed Sato K, Fujita S: Dendritic cells: nature and classification. Allergol Int. 2007, 56: 183-191. 10.2332/allergolint.R-06-139.CrossRefPubMed
33.
go back to reference Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, Chevailler A, Mouthon L, Weill B, Bruneval P, Kazatchkine MD, Kaveri SV: Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood. 2003, 101: 758-765. 10.1182/blood-2002-05-1447.CrossRefPubMed Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, Chevailler A, Mouthon L, Weill B, Bruneval P, Kazatchkine MD, Kaveri SV: Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood. 2003, 101: 758-765. 10.1182/blood-2002-05-1447.CrossRefPubMed
34.
go back to reference Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW: Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest. 2005, 115: 2914-2923. 10.1172/JCI24772.CrossRefPubMedPubMedCentral Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW: Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest. 2005, 115: 2914-2923. 10.1172/JCI24772.CrossRefPubMedPubMedCentral
35.
go back to reference Hartwig C, Mazzega M, Constabel H, Krishnaswamy JK, Gessner JE, Braun A, Tschernig T, Behrens GM: Fcgamma receptor-mediated antigen uptake by lung DC contributes to allergic airway hyper-responsiveness and inflammation. Eur J Immunol. 2010, 40: 1284-1295. 10.1002/eji.200939900.CrossRefPubMed Hartwig C, Mazzega M, Constabel H, Krishnaswamy JK, Gessner JE, Braun A, Tschernig T, Behrens GM: Fcgamma receptor-mediated antigen uptake by lung DC contributes to allergic airway hyper-responsiveness and inflammation. Eur J Immunol. 2010, 40: 1284-1295. 10.1002/eji.200939900.CrossRefPubMed
36.
go back to reference Akiyama K, Ebihara S, Yada A, Matsumura K, Aiba S, Nukiwa T, Takai T: Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells. J Immunol. 2003, 170: 1641-1648.CrossRefPubMed Akiyama K, Ebihara S, Yada A, Matsumura K, Aiba S, Nukiwa T, Takai T: Targeting apoptotic tumor cells to Fc gamma R provides efficient and versatile vaccination against tumors by dendritic cells. J Immunol. 2003, 170: 1641-1648.CrossRefPubMed
37.
go back to reference Liu Y, Gao X, Masuda E, Redecha PB, Blank MC, Pricop L: Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. J Immunol. 2006, 177: 8440-8447.CrossRefPubMed Liu Y, Gao X, Masuda E, Redecha PB, Blank MC, Pricop L: Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. J Immunol. 2006, 177: 8440-8447.CrossRefPubMed
38.
go back to reference Dharajiya N, Vaidya SV, Murai H, Cardenas V, Kurosky A, Boldogh I, Sur SA: FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma. PLoS One. 2010, 5: e9337-10.1371/journal.pone.0009337.CrossRefPubMedPubMedCentral Dharajiya N, Vaidya SV, Murai H, Cardenas V, Kurosky A, Boldogh I, Sur SA: FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma. PLoS One. 2010, 5: e9337-10.1371/journal.pone.0009337.CrossRefPubMedPubMedCentral
39.
go back to reference Yamamoto M, Kobayashi K, Ishikawa Y, Nakata K, Funada Y, Kotani Y, Masuda A, Takai T, Azuma T, Yoshida M, Nishimura Y: The inhibitory effects of intravenous administration of rabbit IgG on airway inflammation are dependent on Fcγ receptor IIb on CD11c+ dendritic cells in murine model. Clin Exp Immunol. 2010, 162: 315-324. 10.1111/j.1365-2249.2010.04243.x.CrossRefPubMedPubMedCentral Yamamoto M, Kobayashi K, Ishikawa Y, Nakata K, Funada Y, Kotani Y, Masuda A, Takai T, Azuma T, Yoshida M, Nishimura Y: The inhibitory effects of intravenous administration of rabbit IgG on airway inflammation are dependent on Fcγ receptor IIb on CD11c+ dendritic cells in murine model. Clin Exp Immunol. 2010, 162: 315-324. 10.1111/j.1365-2249.2010.04243.x.CrossRefPubMedPubMedCentral
40.
go back to reference Sehra S, Pynaert G, Tournoy K, Haegeman A, Matthys P, Tagawa Y, Pauwels R, Grooten J: Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma. J Immunol. 2003, 171: 2080-2089.CrossRefPubMed Sehra S, Pynaert G, Tournoy K, Haegeman A, Matthys P, Tagawa Y, Pauwels R, Grooten J: Airway IgG counteracts specific and bystander allergen-triggered pulmonary inflammation by a mechanism dependent on Fc gamma R and IFN-gamma. J Immunol. 2003, 171: 2080-2089.CrossRefPubMed
41.
go back to reference Lambrecht BN, Veerrman MD, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA: Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest. 2000, 106: 551-559. 10.1172/JCI8107.CrossRefPubMedPubMedCentral Lambrecht BN, Veerrman MD, Coyle AJ, Gutierrez-Ramos JC, Thielemans K, Pauwels RA: Myeloid dendritic cells induce Th2 responses to inhaled antigen, leading to eosinophilic airway inflammation. J Clin Invest. 2000, 106: 551-559. 10.1172/JCI8107.CrossRefPubMedPubMedCentral
Metadata
Title
Antigen-Specific IgG ameliorates allergic airway inflammation via Fcγ receptor IIB on dendritic cells
Authors
Yumiko Ishikawa
Kazuyuki Kobayashi
Masatsugu Yamamoto
Kyosuke Nakata
Tetsuya Takagawa
Yasuhiro Funada
Yoshikazu Kotani
Hajime Karasuyama
Masaru Yoshida
Yoshihiro Nishimura
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2011
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-12-42

Other articles of this Issue 1/2011

Respiratory Research 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.